TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
Xi Chen(Baylor College of Medicine), Jennifer A. Pietenpol(Vanderbilt University), Joshua A. Bauer(Vanderbilt University), Jiang Li(First Hospital of China Medical University), W.H. Gray(Vanderbilt University), Brian D. Lehmann(Vanderbilt University Medical Center), Yu Shyr(Vanderbilt University)
Cited by 303
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
|Cancer Cell|2004|1.1k
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|572
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
|Cancer Immunology Research|2016|493